GoHealth, Inc.

Good morning and welcome to Go Health's first quarter 2024 earnings conference call. My name is Victor and I'll be your operator for today's call. At this time, all participants are in listen-only mode. Following the prepared remarks, we will conduct a question and answer session. As a reminder, this conference is being recorded. I will now turn the call over to John Shabe, Vice President of Investor Relations. John, you may begin.

Thank you and good morning. Welcome to Go Health's first quarter 2024 earnings call.

Joining me today are Vijay Kote, Chief Executive Officer, and Jason Scholz, Chief Financial Officer. Today's conference call contains forward-looking statements based on our current expectations. Numerous known and unknown risks and uncertainties may cause actual results to differ materially from those anticipated or projected in these statements. Many of the factors that would determine future results are beyond the company's ability to control or predict. You should not place any undue reliance on forward-looking statements, and the company undertakes no obligation to update or revise any of these statements, whether due to new information, future events, or otherwise. Earlier today, we issued a press release containing our first quarter results of 2024. We have posted the release on the GoHealth website under the Investor Relations tab. In the press release, we have listed a number of risk factors that you should consider in conjunction with our forward-looking statements. We encourage you to consider the other risk factors described in our annual report on Form 10-K filed with the Securities and Exchange Commission for additional information. During this call, we will be discussing certain non-GAAP financial measures. These measures are reconciled to the most directly comparable GAAP financial measure, and the reconciliations are set forth in the press release. You may also refer to the investor presentation posted to the investor relations section of our website for reconciliations of non-GAAP measures to the most comparable GAAP measures discussed this earnings call. I will now turn the call over to Go Health CEO Vijay Kote.